TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration.
about
TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
TLR signaling inhibitor, pheny ...... cell viability and migration.
@en
TLR signaling inhibitor, pheny ...... cell viability and migration.
@nl
type
label
TLR signaling inhibitor, pheny ...... cell viability and migration.
@en
TLR signaling inhibitor, pheny ...... cell viability and migration.
@nl
prefLabel
TLR signaling inhibitor, pheny ...... cell viability and migration.
@en
TLR signaling inhibitor, pheny ...... cell viability and migration.
@nl
P2093
P2860
P356
P1433
P1476
TLR signaling inhibitor, pheny ...... cell viability and migration.
@en
P2093
Anthony L Schwartz
Eric Dickerson
Kelly D McCall
Nilesh Dagia
Ramiro Malgor
P2860
P304
113295-113302
P356
10.18632/ONCOTARGET.10358
P407
P577
2016-07-01T00:00:00Z